DUBLIN–(BUSINESS WIRE)–The “Dental Practice Management Software Market Research Report by Deployment (Cloud-based and On-premise), Application, State – United States Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering.
The United States Dental Practice Management Software Market size was estimated at USD 127.07 million in 2021, USD 146.55 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 11.72% to reach USD 247.16 million by 2027.
Market Segmentation & Coverage:
This research report categorizes the Dental Practice Management Software to forecast the revenues and analyze the trends in each of the following sub-markets:
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
6. Dental Practice Management Software Market, by Deployment
6.1. Introduction
6.2. Cloud-based
6.3. On-premise
7. Dental Practice Management Software Market, by Application
7.1. Introduction
7.2. Clinical Applications
7.3. Insurance and Claim Tools
7.4. Patient Management & Billing
8. California Dental Practice Management Software Market
9. Florida Dental Practice Management Software Market
10. Illinois Dental Practice Management Software Market
11. New York Dental Practice Management Software Market
12. Ohio Dental Practice Management Software Market
13. Pennsylvania Dental Practice Management Software Market
14. Texas Dental Practice Management Software Market
15. Competitive Landscape
16. Company Usability Profiles
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/j52mj4
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
The companies are now moving forward with the import permit application process.Following expected approval of…
New York, New York--(Newsfile Corp. - April 15, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM)…
Dr. Chung brings expertise in scaling medical teams to Ezra’s mission of making early cancer…
RMAT designation was granted based on promising clinical data from the ongoing Phase 1/2 trial…
CARMEL, Ind., April 15, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE…
Study Highlights Critical Influence of AI-Driven Reputation on Pharma Market Leaders and New EntrantsCAMPBELL, Calif.…